Business UpdateJul 27, 2026, 08:56 AM
PRF Technologies Raises $10M, Highlights Biotech & AI Momentum
AI Summary
PRF Technologies Ltd. issued a Letter to Shareholders, announcing it raised $10 million through an equity line facility, significantly strengthening its financial position. The company highlighted building momentum across its biotechnology and AI-driven energy platforms. Key advancements include LayerBio's preparations for the Phase 2 clinical trial of OcuRing™-K and DeepSolar's validation of its Predict™ platform with real-world data, expansion into Battery-to-Revenue Intelligence, and joining the NVIDIA Connect program.
Key Highlights
- Raised $10 million through an equity line facility, strengthening the balance sheet.
- LayerBio is advancing operational and clinical preparations for the planned Phase 2 clinical trial of OcuRing™-K.
- Reported expanded preclinical results for PRF-110, showing sustained 72-hour analgesic activity.
- DeepSolar validated its Predict™ platform with real-world European market data.
- DeepSolar expanded its platform with Battery-to-Revenue Intelligence and joined the NVIDIA Connect program.
Price Impact
More from PRFX